Literature DB >> 22209964

Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.

Yuan-Ti Lee1, Shiuan-Chih Chen, Ling-Yuh Shyu, Meng-Chih Lee, Tzu-Chin Wu, Shih-Ming Tsao, Shun-Fa Yang.   

Abstract

BACKGROUND: We identified the relationship between plasma level changes of cathepsin B and cystatin C before and after antibiotic treatment in hospitalized adult patients with community-acquired pneumonia (CAP).
METHODS: We collected blood specimens from 61 adult patients with CAP before and after antibiotic treatment and from 60 healthy controls and measured the plasma concentrations of cathepsin B and cystatin C expression using the enzyme-linked immunosorbent assay (ELISA). The APACHE II, CURB-65, and Pneumonia Severity Index (PSI) scores were determined to assess CAP severity in patients upon initial hospitalization.
RESULTS: The results showed a decline in the number of WBCs and neutrophils, with decreases in the concentrations of CRP, cathepsin B, cystatin C, and the cathepsin B/cystatin C ratio being observed after antibiotic treatment. The plasma concentration of cathepsin B correlated with severity of CAP with the PSI score (r=0.290, p=0.025) and the CURB-65 score (r=0.258, p=0.047), respectively. The plasma concentration of cystatin C correlated with the APACHE II score (r=0.523, p<0.001), severity of CAP in the PSI score (r=0.721, p<0.001) and the CURB-65 score (r=0.609, p<0.001), respectively.
CONCLUSIONS: Cathepsin B and cystatin C may play a role in the diagnosis and clinical assessment of the severity of CAP, which could potentially guide the development of treatment strategies.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209964     DOI: 10.1016/j.cca.2011.12.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.

Authors:  Yuan-Hung Yeh; Junn-Liang Chang; Pei-Ching Hsiao; Shih-Ming Tsao; Chien Huang Lin; Shang-Jyh Kao; Ming-Chih Chou; Shun-Fa Yang; Ming-Hsien Chien
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

Review 2.  Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.

Authors:  Yanwen Qin; Xu Cao; Yaoguo Yang; Guo-Ping Shi
Journal:  Future Cardiol       Date:  2013-01

3.  Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients.

Authors:  Ming Zhang; Yali Li; Xia Yang; Hu Shan; Qiuhong Zhang; Zongjuan Ming; Yingying Xie; Haijuan Chen; Yanqin Liu; Jie Zhang
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

4.  Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients.

Authors:  Hsiang-Ling Wang; Pei-Ching Hsiao; Hsiu-Ting Tsai; Chao-Bin Yeh; Shun-Fa Yang
Journal:  Int J Mol Sci       Date:  2013-11-19       Impact factor: 5.923

5.  Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia.

Authors:  Feilong Yang; Dawei Li; Yu Di; Yongzhen Zhang; Yuanwei Zang; Juchao Ren; Lei Yan; Zunlin Zhou; Hainan Liu; Zhonghua Xu
Journal:  Biomed Res Int       Date:  2017-07-24       Impact factor: 3.411

6.  Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors.

Authors:  Hui Wang; Lijian Gao; Cuiyu Meng; Nengwang Yu; Feilong Yang; Cong Zhang; Dawei Li; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Biomed Res Int       Date:  2018-01-29       Impact factor: 3.411

7.  Serum Cystatin C Levels in COPD: Potential Diagnostic Value and Relation between Respiratory Functions.

Authors:  Selda Telo; Mutlu Kuluöztürk; Figen Deveci; Gamze Kırkıl; Önsel Öner; Dilara Kaman
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

8.  Circulating level of high mobility group box‑1 predicts the severity of community‑acquired pneumonia: Regulation of inflammatory responses via the c‑Jun N‑terminal signaling pathway in macrophages.

Authors:  Hsiang-Ling Wang; Shih-Ming Tsao; Chao-Bin Yeh; Ying-Erh Chou; Shun-Fa Yang
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.